118 related articles for article (PubMed ID: 12581011)
1. RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancer.
Kamai T; Kawakami S; Koga F; Arai G; Takagi K; Arai K; Tsujii T; Yoshida KI
BJU Int; 2003 Feb; 91(3):234-8. PubMed ID: 12581011
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter.
Kamai T; Takagi K; Asami H; Ito Y; Arai K; Yoshida KI
BJU Int; 2000 Jul; 86(1):14-9. PubMed ID: 10886076
[TBL] [Abstract][Full Text] [Related]
3. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer.
Kamai T; Tsujii T; Arai K; Takagi K; Asami H; Ito Y; Oshima H
Clin Cancer Res; 2003 Jul; 9(7):2632-41. PubMed ID: 12855641
[TBL] [Abstract][Full Text] [Related]
4. Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer.
Ishida M; Mikami S; Kikuchi E; Kosaka T; Miyajima A; Nakagawa K; Mukai M; Okada Y; Oya M
Carcinogenesis; 2010 Feb; 31(2):287-95. PubMed ID: 19755661
[TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of RhoA and NF-ΚB in human gastric carcinoma].
Su XJ; Tang ZF; Li Q; Li HL; Li LL; Liu M; Zhou YN
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):276-9. PubMed ID: 21575498
[TBL] [Abstract][Full Text] [Related]
6. PTP4A3 Independently Predicts Metastasis and Survival in Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.
Yeh HC; Li CC; Huang CN; Hour TC; Yeh BW; Li WM; Liang PI; Chang LL; Li CF; Wu WJ
J Urol; 2015 Nov; 194(5):1449-55. PubMed ID: 26070892
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma: an analysis of 368 radical nephroureterectomy specimens].
Wang Y; He HY
Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):681-686. PubMed ID: 27760608
[No Abstract] [Full Text] [Related]
8. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
Akao J; Matsuyama H; Yamamoto Y; Hara T; Kawai Y; Sakano S; Ohmi C; Gondo T; Naito K
BJU Int; 2008 Aug; 102(5):572-5. PubMed ID: 18485032
[TBL] [Abstract][Full Text] [Related]
10. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.
Ouzzane A; Colin P; Xylinas E; Pignot G; Ariane MM; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Bruyère F; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M;
Eur Urol; 2011 Dec; 60(6):1258-65. PubMed ID: 21665356
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract.
Miyata Y; Kanda S; Nomata K; Eguchi J; Kanetake H
J Urol; 2005 Jan; 173(1):56-60. PubMed ID: 15592025
[TBL] [Abstract][Full Text] [Related]
12. Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis.
Miyata Y; Kanda S; Ohba K; Nomata K; Eguchi J; Hayashida Y; Kanetake H
J Urol; 2006 Jul; 176(1):348-53. PubMed ID: 16753442
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter.
Kamijima S; Tobe T; Suyama T; Ueda T; Igarashi T; Ichikawa T; Ito H
Int J Urol; 2005 Nov; 12(11):941-7. PubMed ID: 16351648
[TBL] [Abstract][Full Text] [Related]
14. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location.
Zigeuner RE; Hutterer G; Chromecki T; Rehak P; Langner C
BJU Int; 2006 Dec; 98(6):1181-6. PubMed ID: 17125475
[TBL] [Abstract][Full Text] [Related]
15. Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours.
Bin X; Roy OP; Ghiraldi E; Manglik N; Liang T; Vira M; Kavoussi LR
BJU Int; 2012 Dec; 110(11 Pt B):E514-9. PubMed ID: 22578024
[TBL] [Abstract][Full Text] [Related]
16. Squamous differentiation and prognosis in upper urinary tract urothelial carcinoma.
Makise N; Morikawa T; Kawai T; Nakagawa T; Kume H; Homma Y; Fukayama M
Int J Clin Exp Pathol; 2015; 8(6):7203-9. PubMed ID: 26261615
[TBL] [Abstract][Full Text] [Related]
17. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
18. Expression of RhoA and RhoC in colorectal carcinoma and its relations with clinicopathological parameters.
Wang HB; Liu XP; Liang J; Yang K; Sui AH; Liu YJ
Clin Chem Lab Med; 2009; 47(7):811-7. PubMed ID: 19499974
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of EZH2 expression in upper urinary tract carcinoma.
Hayashi A; Morikawa T; Kawai T; Kume H; Ishikawa S; Homma Y; Fukayama M
Virchows Arch; 2014 Apr; 464(4):463-71. PubMed ID: 24446035
[TBL] [Abstract][Full Text] [Related]
20. Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract.
Ohtsuka Y; Kawakami S; Fujii Y; Koga F; Saito K; Ando N; Takizawa T; Kageyama Y; Kihara K
BJU Int; 2006 Jun; 97(6):1322-6. PubMed ID: 16686732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]